Item 2.02 매우중요

실적 발표

3분기 순손실은 2,540만 달러로 전년 동기 2,650만 달러보다 감소했습니다. 매출과 EPS 정보는 공시에 포함되지 않았습니다. R&D 비용은 2,110만 달러로 전년 동기 2,200만 달러보다 감소했으며, 현금 보유액은 7,860만 달러입니다.

Item 7.01 중요

공정공시

Item 7.01 of this Report (including Exhibit 99.2), is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing. The Company’s submission of this Report shall not be deemed an admission as to the materiality of any information re...